Details for New Drug Application (NDA): 209150
✉ Email this page to a colleague
The generic ingredient in THIOTEPA is thiotepa. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
Summary for 209150
Tradename: | THIOTEPA |
Applicant: | Hengrui Pharma |
Ingredient: | thiotepa |
Patents: | 0 |
Pharmacology for NDA: 209150
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 209150
Suppliers and Packaging for NDA: 209150
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
THIOTEPA | thiotepa | INJECTABLE;INJECTION | 209150 | ANDA | Sagent Pharmaceuticals | 25021-246 | 25021-246-02 | 1 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/VIAL | ||||
Approval Date: | May 4, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription